TCA Cycle Intermediates Mass Spectrometry Analysis

TCA cycle intermediates mass spectrometry analysis enables sensitive, quantitative measurement of central carbon metabolism metabolites such as citrate, alpha-ketoglutarate, succinate, fumarate, and malate in cells, tissues, and biological fluids. Using LC-MS/MS, GC-MS, and stable isotope dilution strategies, this analytical platform supports breakthrough research in cancer metabolism, mitochondrial dysfunction, immunometabolism, and metabolic disease with high specificity and multiplexed detection capability.

Technical Overview

The tricarboxylic acid (TCA) cycle, also known as the citric acid cycle or Krebs cycle, is the central metabolic hub of aerobic organisms, operating in the mitochondrial matrix to oxidize acetyl-CoA derived from carbohydrates, fatty acids, and amino acids into carbon dioxide while generating NADH and FADH2 that drive oxidative phosphorylation. Beyond its catabolic role, the TCA cycle functions as a biosynthetic crossroads: citrate export supports de novo lipogenesis, alpha-ketoglutarate feeds amino acid and nitrogen metabolism, oxaloacetate enables gluconeogenesis and aspartate biosynthesis, and succinate and fumarate act as signaling molecules that regulate hypoxia responses, epigenetic states, and inflammation.

Quantitative analysis of TCA cycle intermediates presents substantial analytical challenges. These metabolites are highly polar and anionic, occur at low micromolar concentrations, and include unstable species such as oxaloacetate, which undergoes spontaneous decarboxylation, and acyl-CoA thioesters, which are labile to hydrolysis. Structural isomers such as citrate and isocitrate require chromatographic resolution for accurate quantification. Mass spectrometry, particularly when coupled with liquid chromatography (LC-MS/MS), gas chromatography (GC-MS), or ion chromatography (IC-MS), overcomes these obstacles by providing high sensitivity, structural specificity, and the ability to quantify multiple intermediates simultaneously in a single injection. Stable isotope dilution using isotopically labeled internal standards further ensures accuracy across complex biological matrices.

Dysregulation of TCA cycle metabolites is now recognized as a hallmark of numerous pathological states, including oncogenic transformations driven by IDH1/2, SDH, and FH mutations, primary mitochondrial diseases, neurodegenerative disorders, chronic inflammation, and metabolic syndrome. Accurate mass spectrometric quantification of these intermediates therefore provides critical mechanistic insight and translational biomarker value.

Testing Samples

We accept a wide range of biological sample types for TCA cycle intermediate analysis. Because these metabolites turn over rapidly, proper quenching, cold-chain handling, and avoidance of repeated freeze-thaw cycles are essential for reliable results. Our technical team provides detailed sampling and shipping protocols for each matrix.

Cell Samples

Cultured adherent and suspension cells from mammalian, bacterial, yeast, or other origins are suitable for analysis. Cells should be rapidly washed to remove extracellular metabolites and quenched with pre-chilled extraction solvent (typically 80% methanol at -80°C) to halt enzymatic activity immediately. Recommended input is generally 1-5 million cells per sample, although optimized methods can accommodate lower cell numbers for limited biological models such as sorted immune subsets or organoids.

Tissue Samples

Animal tissues including liver, heart, brain, skeletal muscle, kidney, adipose tissue, and tumor xenografts are routinely analyzed. Tissues should be dissected rapidly, flash-frozen in liquid nitrogen, and stored at -80°C until extraction. A minimum of 20-50 mg of tissue is recommended per analysis. Plant tissues and microbial biomass can also be processed using adapted extraction protocols.

Biofluid Samples

Plasma, serum, urine, cerebrospinal fluid, and cell culture medium can be analyzed. Blood samples should be collected using appropriate anticoagulants, processed promptly at low temperature, and stored frozen to minimize ex vivo metabolic drift. Urine samples benefit from normalization to creatinine or osmolality.

Mitochondrial Preparations

Isolated mitochondria from cultured cells or tissues can be analyzed to localize metabolic alterations to the mitochondrial compartment. Samples should be pelleted, snap-frozen, and submitted with protein concentration information for normalization purposes.

Testing Items

Our targeted mass spectrometry panels quantify the canonical TCA cycle intermediates together with closely connected metabolites of central carbon metabolism. All analytes are reported with absolute concentrations and full QC documentation.

• Citrate
• Isocitrate
• cis-Aconitate
• Alpha-ketoglutarate (2-oxoglutarate)
• Succinate
• Fumarate
• Malate
• Oxaloacetate
• Pyruvate and lactate
• Acetyl-CoA and succinyl-CoA
• 2-Hydroxyglutarate (2-HG, oncometabolite)
• Itaconate (immunometabolite)
• Glutamate, aspartate, and related amino acids
• NAD+ and NADH (total pool or ratio analysis)

Custom panel configurations are available. Clients may request addition of related pathway metabolites, such as carnitine derivatives, nucleotides, or glycolytic intermediates, to build an integrated metabolic profile tailored to a specific research question.

Testing Methods

Sample Preparation

Metabolites are extracted using pre-chilled organic solvent systems, typically cold 80% methanol or methanol-water-acetonitrile mixtures, applied directly to frozen samples to achieve simultaneous quenching and extraction. Isotopically labeled internal standards (such as uniformly 13C-labeled analogs of citrate, succinate, fumarate, malate, and alpha-ketoglutarate) are added at the beginning of extraction to correct for matrix effects and recovery variation. Protein content, cell number, or tissue weight is measured separately for sample normalization.

LC-MS/MS Analysis

GC-MS Analysis

For laboratories requiring GC-MS confirmation or complementary coverage, volatile derivatives of TCA intermediates are generated using silylation reagents such as MSTFA or through esterification chemistry. GC-MS provides high chromatographic resolution and robust library-based identification, and is particularly useful for confirming molecular identity and for applications with established GC-MS workflows.

Stable Isotope Tracing and Metabolic Flux Analysis

Beyond pool-size quantification, we offer 13C isotope tracing experiments in which cells or animals are supplied with labeled substrates such as U-13C6 glucose, U-13C5 glutamine, or U-13C acetate. Mass isotopologue distributions of each TCA intermediate are measured to quantify carbon entry, cycle turnover, and pathway contributions. These data support classical flux analysis and mechanistic studies of reductive carboxylation, anaplerosis, and mitochondrial dysfunction.

Data Processing and Quality Control

Every batch includes calibration standards, pooled quality control samples injected at regular intervals, blanks, and replicates to monitor retention time stability, signal drift, and analytical precision. Reports include raw peak areas, internal-standard-corrected concentrations, normalization to the requested basis (per mg tissue, per million cells, per mg protein, or per volume), and clear documentation of method performance metrics such as linearity, limits of detection, and coefficients of variation.

Applications

Cancer Metabolism Research

Mass spectrometric profiling of TCA intermediates is central to oncometabolite research. Mutant IDH1/2 enzymes convert alpha-ketoglutarate to the 2-hydroxyglutarate oncometabolite, while loss-of-function mutations in SDH and FH cause accumulation of succinate and fumarate, all of which inhibit alpha-ketoglutarate-dependent dioxygenases and drive epigenetic remodeling. Our assays support biomarker studies, mechanism-of-action investigations, and pharmacodynamic evaluation of IDH inhibitors.

Mitochondrial Disease and Toxicology

Altered ratios of TCA intermediates provide functional readouts of mitochondrial enzyme deficiencies and drug-induced mitochondrial toxicity. Comparative analysis of substrate-driven intermediate accumulation helps localize defects to specific cycle steps and supports preclinical safety assessment of compounds that impair mitochondrial function.

Immunometabolism

TCA cycle reprogramming is integral to immune cell activation and polarization. Succinate accumulation and itaconate production are established signatures of inflammatory macrophage activation, while citrate export supports prostaglandin and itaconate biosynthesis. Targeted quantification enables mechanistic studies of T cell differentiation, macrophage polarization, and inflammatory disease models.

Metabolic Engineering and Fermentation

In industrial biotechnology, monitoring organic acid intermediates in engineered strains and fermentation broths guides pathway optimization for succinate, citrate, malate, and alpha-ketoglutarate production, as well as strain engineering for valuable biochemical synthesis.

Biomarker Discovery and Clinical Translation

Circulating TCA intermediates in plasma and urine show promise as biomarkers for metabolic syndrome, diabetes, liver disease, renal impairment, and specific inborn errors of metabolism. Validated LC-MS/MS quantification provides the analytical rigor required for translational and clinical research studies.

FAQ

Why is rapid quenching so important for TCA cycle analysis?

TCA intermediates turn over within seconds to minutes, and labile species such as oxaloacetate degrade rapidly after sampling. Immediate quenching with pre-chilled organic solvent at -80°C halts enzymatic activity and preserves the in vivo metabolic state, which is essential for biologically meaningful results.

Can citrate and isocitrate be distinguished from each other?

Yes. These structural isomers have identical masses, so they cannot be separated by mass alone. Our chromatographic methods resolve them, allowing individual quantification of each isomer rather than a combined citrate/isocitrate value.

What sample quantities are required?

Typical requirements are 1-5 million cells, 20-50 mg of tissue, 50-200 microliters of plasma or serum, or equivalent amounts of other matrices. For limited samples such as sorted cells or fine-needle biopsies, please contact our team to discuss miniaturized extraction options.

Do you offer 13C isotope tracing experiments?

Yes. We routinely perform stable isotope tracing with labeled glucose, glutamine, acetate, and other substrates, followed by measurement of mass isotopologue distributions across all TCA intermediates. These experiments quantify pathway flux contributions and are available for cell culture and animal models.

How are results normalized and reported?

Concentrations are normalized to the most appropriate biological unit for each study, including per mg of tissue, per million cells, per mg of protein, or per sample volume. Reports include absolute concentrations, QC data, and method performance parameters, with raw data files available upon request.

What is the typical project timeline?

Standard targeted quantification projects are typically completed within 2-4 weeks after sample receipt, depending on sample number and panel complexity. Isotope tracing and custom panel projects may require additional method development time, which is confirmed during project consultation.